Why Drug Developers Are Going Digital to Support Therapeutic Launches

Gone are the days when effective new medicines could expect to find organic commercial success. With nearly 30% of drug launches failing to meet expectations and an increasingly competitive market, pharmaceutical leaders are adopting new strategies to help patients find and access best-fit treatments.

    By doing so, today’s digital health solutions are changing the very definition of “medical treatment.” Some digital companion apps are clinically validated and insurance-reimbursable, created to be taken alongside drugs, simplifying administration and improving adherence. Their unregulated counterparts are educating patients, supporting providers and advancing the progress of scientific research. All are part of a revolution in connected care, where digital tools are helping:
    • Identify prospective patients earlier
    • Improve adherence and reduce patient leakage
    • Map treatment progress and symptoms